You are currently on the new version of our website. Access the old version .

80 Results Found

  • Feature Paper
  • Article
  • Open Access
10 Citations
4,128 Views
17 Pages

Induction of Survival of Motor Neuron (SMN) Protein Deficiency in Spinal Astrocytes by Small Interfering RNA as an In Vitro Model of Spinal Muscular Atrophy

  • Markus Leo,
  • Linda-Isabell Schmitt,
  • Michael Fleischer,
  • Rebecca Steffen,
  • Cora Osswald,
  • Christoph Kleinschnitz and
  • Tim Hagenacker

5 February 2022

Spinal muscular atrophy (SMA) is a motor neuron disorder leading to progressive loss of ventral horn neurons resulting in muscle wasting. Here we investigate the contribution of spinal astrocytes to the pathogenesis of late-onset SMA forms using a mo...

  • Perspective
  • Open Access
11 Citations
5,562 Views
24 Pages

Proximal spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disorder characterized by motor neuron loss and subsequent atrophy of skeletal muscle. SMA is caused by deficiency of the essential survival motor neuron (SMN) protein...

  • Review
  • Open Access
16 Citations
10,469 Views
26 Pages

30 July 2024

Spinal muscular atrophy (SMA) is a severe genetic disorder characterized by the loss of motor neurons, leading to progressive muscle weakness, loss of mobility, and respiratory complications. In its most severe forms, SMA can result in death within t...

  • Review
  • Open Access
51 Citations
12,624 Views
17 Pages

26 January 2022

Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disorder and one of the most common genetic causes of infant death. It is characterized by progressive weakness of the muscles, loss of ambulation, and death from respiratory c...

  • Article
  • Open Access
22 Citations
7,496 Views
16 Pages

A Perturbed MicroRNA Expression Pattern Characterizes Embryonic Neural Stem Cells Derived from a Severe Mouse Model of Spinal Muscular Atrophy (SMA)

  • Andrea Luchetti,
  • Silvia Anna Ciafrè,
  • Michela Murdocca,
  • Arianna Malgieri,
  • Andrea Masotti,
  • Massimo Sanchez,
  • Maria Giulia Farace,
  • Giuseppe Novelli and
  • Federica Sangiuolo

6 August 2015

Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder and the leading genetic cause of death in infants. Despite the disease-causing gene, survival motor neuron (SMN1), encodes a ubiquitous protein, SMN1 deficiency preferentially affe...

  • Review
  • Open Access
17 Citations
8,526 Views
19 Pages

The SMN Complex at the Crossroad between RNA Metabolism and Neurodegeneration

  • Irene Faravelli,
  • Giulietta M. Riboldi,
  • Paola Rinchetti and
  • Francesco Lotti

23 January 2023

In the cell, RNA exists and functions in a complex with RNA binding proteins (RBPs) that regulate each step of the RNA life cycle from transcription to degradation. Central to this regulation is the role of several molecular chaperones that ensure th...

  • Article
  • Open Access
4 Citations
4,799 Views
14 Pages

8 December 2017

Spinal muscular atrophy is due to mutations affecting the SMN1 gene coding for the full-length protein (survival motor neuron; SMN) and the SMN2 gene that preferentially generates an exon 7-deleted protein (SMNΔ7) by alternative splicing. To study SM...

  • Article
  • Open Access
7 Citations
4,076 Views
20 Pages

25 June 2022

Human survival motor neuron 1 (SMN1) codes for SMN, an essential housekeeping protein involved in most aspects of RNA metabolism. Deletions or mutations of SMN1 lead to spinal muscular atrophy (SMA), a devastating neurodegenerative disease linked to...

  • Article
  • Open Access
20 Citations
5,627 Views
29 Pages

Nusinersen Modulates Proteomics Profiles of Cerebrospinal Fluid in Spinal Muscular Atrophy Type 1 Patients

  • Laura Bianchi,
  • Maria Sframeli,
  • Lorenza Vantaggiato,
  • Gian Luca Vita,
  • Annamaria Ciranni,
  • Francesca Polito,
  • Rosaria Oteri,
  • Eloisa Gitto,
  • Fabrizio Di Giuseppe and
  • M’hammed Aguennouz
  • + 5 authors

Spinal muscular atrophy (SMA) type 1 is a severe infantile autosomal-recessive neuromuscular disorder caused by a survival motor neuron 1 gene (SMN1) mutation and characterized by progressive muscle weakness. Without supportive care, SMA type 1 is ra...

  • Article
  • Open Access
14 Citations
6,194 Views
33 Pages

High Concentration of an ISS-N1-Targeting Antisense Oligonucleotide Causes Massive Perturbation of the Transcriptome

  • Eric William Ottesen,
  • Diou Luo,
  • Natalia Nikolaevna Singh and
  • Ravindra Narayan Singh

Intronic splicing silencer N1 (ISS-N1) located within Survival Motor Neuron 2 (SMN2) intron 7 is the target of a therapeutic antisense oligonucleotide (ASO), nusinersen (Spinraza), which is currently being used for the treatment of spinal muscular at...

  • Article
  • Open Access
18 Citations
5,080 Views
21 Pages

Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy

  • Francesco Errico,
  • Carmen Marino,
  • Manuela Grimaldi,
  • Tommaso Nuzzo,
  • Valentina Bassareo,
  • Valeria Valsecchi,
  • Chiara Panicucci,
  • Elia Di Schiavi,
  • Tommaso Mazza and
  • Alessandro Usiello
  • + 6 authors

6 October 2022

Intrathecal delivery of Nusinersen–an antisense oligonucleotide that promotes survival motor neuron (SMN) protein induction–is an approved therapy for spinal muscular atrophy (SMA). Here, we employed nuclear magnetic resonance (NMR) spect...

  • Review
  • Open Access
74 Citations
17,941 Views
22 Pages

Spinal muscular atrophy (SMA) is a leading genetic cause of infant death worldwide that is characterized by loss of spinal motor neurons leading to muscle weakness and atrophy. SMA results from the loss of survival motor neuron 1 (SMN1) gene but rete...

  • Systematic Review
  • Open Access
17 Citations
7,256 Views
12 Pages

The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • Kirellos Said Abbas,
  • Mennatullah Mohamed Eltaras,
  • Nahla Ahmed El-Shahat,
  • Basel Abdelazeem,
  • Mahmoud Shaqfeh and
  • James Robert Brašić

1 February 2022

Background and objectives: Spinal muscular atrophy (SMA) is a neurodegenerative disease that leads to progressive proximal muscle weakness and muscle atrophy. To assess the beneficial and adverse effects of nusinersen, a promising intervention for SM...

  • Review
  • Open Access
28 Citations
9,240 Views
21 Pages

Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape

  • Aleksei S. Ponomarev,
  • Daria S. Chulpanova,
  • Lina M. Yanygina,
  • Valeriya V. Solovyeva and
  • Albert A. Rizvanov

6 September 2023

Spinal muscular atrophy (SMA) is a rare autosomal recessive neuromuscular disease that is characterized by progressive muscle atrophy (degeneration), including skeletal muscles in charge of the ability to move. SMA is caused by defects in the SMN1 ge...

  • Review
  • Open Access
1 Citations
3,069 Views
21 Pages

13 August 2024

Spinal muscular atrophy (SMA) is one of the most frequent causes of death in childhood. The disease’s molecular basis is deletion or mutations in the SMN1 gene, which produces reduced survival motor neuron protein (SMN) levels. As a result, the...

  • Review
  • Open Access
32 Citations
7,890 Views
13 Pages

21 August 2021

After 26 years of discovery of the determinant survival motor neuron 1 and the modifier survival motor neuron 2 genes (SMN1 and SMN2, respectively), three SMN-dependent specific therapies are already approved by FDA and EMA and, as a consequence, wor...

  • Article
  • Open Access
9 Citations
4,050 Views
25 Pages

SMN Is Physiologically Downregulated at Wild-Type Motor Nerve Terminals but Aggregates Together with Neurofilaments in SMA Mouse Models

  • Julio Franco-Espin,
  • Alaó Gatius,
  • José Ángel Armengol,
  • Saravanan Arumugam,
  • Mehri Moradi,
  • Michael Sendtner,
  • Jordi Calderó and
  • Lucia Tabares

20 October 2022

Survival motor neuron (SMN) is an essential and ubiquitously expressed protein that participates in several aspects of RNA metabolism. SMN deficiency causes a devastating motor neuron disease called spinal muscular atrophy (SMA). SMN forms the core o...

  • Article
  • Open Access
4 Citations
2,339 Views
14 Pages

Real-Time PCR-Based Screening for Homozygous SMN2 Deletion Using Residual Dried Blood Spots

  • Yoshihiro Bouike,
  • Makoto Sakima,
  • Yuya Taninishi,
  • Takanori Matsutani,
  • Yoriko Noguchi,
  • Ryosuke Bo,
  • Hiroyuki Awano and
  • Hisahide Nishio

29 November 2023

The survival motor neuron 2 (SMN2) gene is a recognized modifier gene of spinal muscular atrophy (SMA). However, our knowledge about the role of SMN2—other than its modification of SMA phenotypes—is very limited. Discussions regarding the...

  • Review
  • Open Access
18 Citations
9,538 Views
17 Pages

Alternative Splicing Role in New Therapies of Spinal Muscular Atrophy

  • Jan Lejman,
  • Grzegorz Zieliński,
  • Piotr Gawda and
  • Monika Lejman

28 August 2021

It has been estimated that 80% of the pre-mRNA undergoes alternative splicing, which exponentially increases the flow of biological information in cellular processes and can be an attractive therapeutic target. It is a crucial mechanism to increase g...

  • Article
  • Open Access
24 Citations
3,539 Views
14 Pages

Targeted-Deletion of a Tiny Sequence via Prime Editing to Restore SMN Expression

  • Miaojin Zhou,
  • Shuqing Tang,
  • Nannan Duan,
  • Mi Xie,
  • Zhuo Li,
  • Mai Feng,
  • Lingqian Wu,
  • Zhiqing Hu and
  • Desheng Liang

Spinal muscular atrophy (SMA) is a devastating autosomal recessive motor neuron disease associated with mutations in the survival motor neuron 1 (SMN1) gene, the leading genetic cause of infant mortality. A nearly identical copy gene (SMN2) is retain...

  • Review
  • Open Access
9 Citations
5,596 Views
16 Pages

Spinal muscular atrophy (SMA) is a severe neuromuscular disorder that is caused by mutations in the survival motor neuron 1 (SMN1) gene, hindering the production of functional survival motor neuron (SMN) proteins. Antisense oligonucleotides (ASOs), a...

  • Review
  • Open Access
29 Citations
7,967 Views
30 Pages

Mitochondrial Dysfunction in Spinal Muscular Atrophy

  • Eleonora Zilio,
  • Valentina Piano and
  • Brunhilde Wirth

17 September 2022

Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder caused by recessive mutations in the SMN1 gene, globally affecting ~8–14 newborns per 100,000. The severity of the disease depends on the residual levels of functional surviv...

  • Review
  • Open Access
117 Citations
16,635 Views
20 Pages

Spinal muscular atrophy (SMA) is a congenital neuromuscular disorder characterized by motor neuron loss, resulting in progressive weakness. SMA is notable in the health care community because it accounts for the most common cause of infant death resu...

  • Article
  • Open Access
1 Citations
3,988 Views
13 Pages

Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of SMN2 in SMA Type I Fibroblasts

  • Jarichad Toosaranont,
  • Sukanya Ruschadaariyachat,
  • Warasinee Mujchariyakul,
  • Jantarika Kumar Arora,
  • Varodom Charoensawan,
  • Bhoom Suktitipat,
  • Thomas N. Palmer,
  • Sue Fletcher,
  • Steve D. Wilton and
  • Chalermchai Mitrpant

Spinal muscular atrophy (SMA) is a severe, debilitating neuromuscular condition characterised by loss of motor neurons and progressive muscle wasting. SMA is caused by a loss of expression of SMN1 that encodes the survival motor neuron (SMN) protein...

  • Review
  • Open Access
13 Citations
6,925 Views
20 Pages

Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy

  • Laurent Servais,
  • Lindsey Lee Lair,
  • Anne M. Connolly,
  • Barry J. Byrne,
  • Karen S. Chen,
  • Vlad Coric,
  • Irfan Qureshi,
  • Susan Durham,
  • Daniel J. Campbell and
  • Clifford Bechtold
  • + 2 authors

24 September 2024

Spinal muscular atrophy (SMA) is a rare, genetic neurodegenerative disorder caused by insufficient production of survival motor neuron (SMN) protein. Diminished SMN protein levels lead to motor neuron loss, causing muscle atrophy and weakness that im...

  • Article
  • Open Access
5 Citations
3,649 Views
10 Pages

Detection of Spinal Muscular Atrophy Patients Using Dried Saliva Spots

  • Yogik Onky Silvana Wijaya,
  • Hisahide Nishio,
  • Emma Tabe Eko Niba,
  • Kentaro Okamoto,
  • Haruo Shintaku,
  • Yasuhiro Takeshima,
  • Toshio Saito,
  • Masakazu Shinohara and
  • Hiroyuki Awano

14 October 2021

Spinal muscular atrophy (SMA) is a lower motor neuron disease, once considered incurable. The main symptoms are muscle weakness and muscular atrophy. More than 90% of cases of SMA are caused by homozygous deletion of survival motor neuron 1 (SMN1). E...

  • Article
  • Open Access
11 Citations
4,533 Views
14 Pages

Effects of Survival Motor Neuron Protein on Germ Cell Development in Mouse and Human

  • Wei-Fang Chang,
  • Min Peng,
  • Jing Hsu,
  • Jie Xu,
  • Huan-Chieh Cho,
  • Hsiu-Mei Hsieh-Li,
  • Ji-Long Liu,
  • Chung-Hao Lu and
  • Li-Ying Sung

Survival motor neuron (SMN) is ubiquitously expressed in many cell types and its encoding gene, survival motor neuron 1 gene (SMN1), is highly conserved in various species. SMN is involved in the assembly of RNA spliceosomes, which are important for...

  • Article
  • Open Access
10 Citations
4,836 Views
15 Pages

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy

  • Emma Tabe Eko Niba,
  • Hisahide Nishio,
  • Yogik Onky Silvana Wijaya,
  • Mawaddah Ar Rochmah,
  • Toru Takarada,
  • Atsuko Takeuchi,
  • Tomokazu Kimizu,
  • Kentaro Okamoto,
  • Toshio Saito and
  • Masakazu Shinohara
  • + 2 authors

24 January 2022

Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disease characterized by defects of lower motor neurons. Approximately 95% of SMA patients are homozygous for survival motor neuron 1 (SMN1) gene deletion, while ~5% carry an...

  • Article
  • Open Access
4 Citations
3,270 Views
14 Pages

Outcomes of a Pilot Newborn Screening Program for Spinal Muscular Atrophy in the Valencian Community

  • Alba Berzal-Serrano,
  • Belén García-Bohórquez,
  • Elena Aller,
  • Teresa Jaijo,
  • Inmaculada Pitarch-Castellano,
  • Dolores Rausell,
  • Gema García-García and
  • José M. Millán

Spinal muscular atrophy (SMA) is a degenerative neuromuscular condition resulting from a homozygous deletion of the survival motor neuron 1 (SMN1) gene in 95% of patients. A timely diagnosis via newborn screening (NBS) and initiating treatment before...

  • Article
  • Open Access
13 Citations
5,302 Views
14 Pages

Survival Motor Neuron Protein Participates in Mouse Germ Cell Development and Spermatogonium Maintenance

  • Wei-Fang Chang,
  • Jie Xu,
  • Tzu-Ying Lin,
  • Jing Hsu,
  • Hsiu-Mei Hsieh-Li,
  • Yuh-Ming Hwu,
  • Ji-Long Liu,
  • Chung-Hao Lu and
  • Li-Ying Sung

The defective human survival motor neuron 1 (SMN1) gene leads to spinal muscular atrophy (SMA), the most common genetic cause of infant mortality. We previously reported that loss of SMN results in rapid differentiation of Drosophila germline stem ce...

  • Review
  • Open Access
32 Citations
12,718 Views
18 Pages

Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy

  • Yang-Jean Li,
  • Tai-Heng Chen,
  • Yan-Zhang Wu and
  • Yung-Hao Tseng

16 December 2020

Spinal muscular atrophy (SMA), the main genetic cause of infant death, is a neurodegenerative disease characterized by the selective loss of motor neurons in the anterior horn of the spinal cord, accompanied by muscle wasting. Pathomechanically, SMA...

  • Review
  • Open Access
4 Citations
3,312 Views
16 Pages

In Search of Spinal Muscular Atrophy Disease Modifiers

  • Daria Chudakova,
  • Ludmila Kuzenkova,
  • Andrey Fisenko and
  • Kirill Savostyanov

18 October 2024

The 5q Spinal Muscular Atrophy (SMA) is a hereditary autosomal recessive disease caused by defects in the survival motor neuron (SMN1) gene encoding survival motor neuron (SMN) protein. Currently, it is the leading cause of infantile mortality worldw...

  • Article
  • Open Access
2 Citations
2,761 Views
17 Pages

Nifedipine Ameliorates Cellular Differentiation Defects of Smn-Deficient Motor Neurons and Enhances Neuromuscular Transmission in SMA Mice

  • Rocio Tejero,
  • Mohammad Alsakkal,
  • Luisa Hennlein,
  • Ana M. Lopez-Cabello,
  • Sibylle Jablonka and
  • Lucia Tabares

In spinal muscular atrophy (SMA), mutations in or loss of the Survival Motor Neuron 1 (SMN1) gene reduce full-length SMN protein levels, which leads to the degeneration of a percentage of motor neurons. In mouse models of SMA, the development and mai...

  • Article
  • Open Access
10 Citations
6,832 Views
10 Pages

Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy

  • Agnese Ramirez,
  • Sebastiano G. Crisafulli,
  • Mafalda Rizzuti,
  • Nereo Bresolin,
  • Giacomo P. Comi,
  • Stefania Corti and
  • Monica Nizzardo

Spinal muscular atrophy (SMA) is an autosomal-recessive childhood motor neuron disease and the main genetic cause of infant mortality. SMA is caused by deletions or mutations in the survival motor neuron 1 (SMN1) gene, which results in SMN protein de...

  • Article
  • Open Access
44 Citations
6,389 Views
12 Pages

Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients

  • Silvia Bonanno,
  • Stefania Marcuzzo,
  • Claudia Malacarne,
  • Eleonora Giagnorio,
  • Riccardo Masson,
  • Riccardo Zanin,
  • Maria Teresa Arnoldi,
  • Francesca Andreetta,
  • Ornella Simoncini and
  • Lorenzo Maggi
  • + 6 authors

Spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by mutations in survival motor neuron (SMN) 1 gene, resulting in a truncated SMN protein responsible for degeneration of brain stem and spinal motor neurons. The paralogous SMN2...

  • Article
  • Open Access
6 Citations
3,385 Views
22 Pages

27 May 2022

Transposable elements (TEs) are interspersed repetitive and mobile DNA sequences within the genome. Better tools for evaluating TE-derived sequences have provided insights into the contribution of TEs to human development and disease. Spinal muscular...

  • Communication
  • Open Access
2 Citations
2,624 Views
13 Pages

SMN Deficiency Destabilizes ABCA1 Expression in Human Fibroblasts: Novel Insights in Pathophysiology of Spinal Muscular Atrophy

  • Francesca Gabanella,
  • Annalisa Onori,
  • Cinzia Pisani,
  • Marco Fiore,
  • Giampiero Ferraguti,
  • Andrea Colizza,
  • Marco de Vincentiis,
  • Marco Ceccanti,
  • Maurizio Inghilleri and
  • Maria Grazia Di Certo
  • + 2 authors

2 February 2023

The deficiency of survival motor neuron protein (SMN) causes spinal muscular atrophy (SMA), a rare neuromuscular disease that affects different organs. SMN is a key player in RNA metabolism regulation. An intriguing aspect of SMN function is its rela...

  • Review
  • Open Access
12 Citations
5,424 Views
21 Pages

Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy

  • Andrés López-Cortés,
  • Gabriela Echeverría-Garcés and
  • María José Ramos-Medina

10 June 2022

The condition known as 5q spinal muscular atrophy (SMA) is a devastating autosomal recessive neuromuscular disease caused by a deficiency of the ubiquitous protein survival of motor neuron (SMN), which is encoded by the SMN1 and SMN2 genes. It is one...

  • Review
  • Open Access
14 Citations
4,507 Views
29 Pages

Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy

  • Marija Babić,
  • Maria Banović,
  • Ivana Berečić,
  • Tea Banić,
  • Mirjana Babić Leko,
  • Monika Ulamec,
  • Alisa Junaković,
  • Janja Kopić,
  • Jadranka Sertić and
  • Goran Šimić
  • + 1 author

1 August 2023

Spinal muscular atrophy (SMA) is a progressive degenerative illness that affects 1 in every 6 to 11,000 live births. This autosomal recessive disorder is caused by homozygous deletion or mutation of the SMN1 gene (survival motor neuron). As a backup,...

  • Review
  • Open Access
120 Citations
24,099 Views
16 Pages

13 July 2020

Spinal muscular atrophy (SMA) is one of the most common autosomal recessive diseases with progressive weakness of skeletal and respiratory muscles, leading to significant disability. The disorder is caused by mutations in the survival motor neuron 1...

  • Feature Paper
  • Article
  • Open Access
4 Citations
4,613 Views
13 Pages

High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts

  • Yogik Onky Silvana Wijaya,
  • Emma Tabe Eko Niba,
  • Hisahide Nishio,
  • Kentaro Okamoto,
  • Hiroyuki Awano,
  • Toshio Saito,
  • Yasuhiro Takeshima and
  • Masakazu Shinohara

13 April 2022

Spinal muscular atrophy (SMA) is caused by survival motor neuron 1 SMN1 deletion. The survival motor neuron 2 (SMN2) encodes the same protein as SMN1 does, but it has a splicing defect of exon 7. Some antisense oligonucleotides (ASOs) have been prove...

  • Article
  • Open Access
1 Citations
2,790 Views
18 Pages

Physiological Features of the Neural Stem Cells Obtained from an Animal Model of Spinal Muscular Atrophy and Their Response to Antioxidant Curcumin

  • Raffaella Adami,
  • Matteo Pezzotta,
  • Francesca Cadile,
  • Beatrice Cuniolo,
  • Gianenrico Rovati,
  • Monica Canepari and
  • Daniele Bottai

The most prevalent rare genetic disease affecting young individuals is spinal muscular atrophy (SMA), which is caused by a loss-of-function mutation in the telomeric gene survival motor neuron (SMN) 1. The high heterogeneity of the SMA pathophysiolog...

  • Article
  • Open Access
2 Citations
2,695 Views
32 Pages

SMN Deficiency Induces an Early Non-Atrophic Myopathy with Alterations in the Contractile and Excitatory Coupling Machinery of Skeletal Myofibers in the SMN∆7 Mouse Model of Spinal Muscular Atrophy

  • María T. Berciano,
  • Alaó Gatius,
  • Alba Puente-Bedia,
  • Alexis Rufino-Gómez,
  • Olga Tarabal,
  • José C. Rodríguez-Rey,
  • Jordi Calderó,
  • Miguel Lafarga and
  • Olga Tapia

19 November 2024

Spinal muscular atrophy (SMA) is caused by a deficiency of the ubiquitously expressed survival motor neuron (SMN) protein. The main pathological hallmark of SMA is the degeneration of lower motor neurons (MNs) with subsequent denervation and atrophy...

  • Article
  • Open Access
11 Citations
3,591 Views
12 Pages

Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan

  • Shoko Sonehara,
  • Ryosuke Bo,
  • Yoshinori Nambu,
  • Kiiko Iketani,
  • Tomoko Lee,
  • Hideki Shimomura,
  • Masaaki Ueda,
  • Yasuhiro Takeshima,
  • Kazumoto Iijima and
  • Hiroyuki Awano
  • + 2 authors

14 December 2023

Newborn screening (NBS) for spinal muscular atrophy (SMA) is necessary, as favorable outcomes can be achieved by treatment with disease-modifying drugs in early infancy. Although SMA-NBS has been initiated in Japan, its clinical results have not been...

  • Article
  • Open Access
6 Citations
3,039 Views
19 Pages

The RNA-Binding Protein SMN as a Novel Player in Laryngeal Squamous Cell Carcinoma

  • Francesca Gabanella,
  • Andrea Colizza,
  • Maria Chiara Mottola,
  • Silvia Francati,
  • Giovanna Blaconà,
  • Carla Petrella,
  • Christian Barbato,
  • Antonio Greco,
  • Massimo Ralli and
  • Maria Grazia Di Certo
  • + 7 authors

16 January 2023

Head and neck squamous cell carcinoma (HNSCC) arises from the mucosal epithelium in the oral cavity, pharynx, sino-nasal region, and larynx. Laryngeal squamous cell carcinoma (LSCC) represents one-third of all head and neck cancers. Dysregulated RNA-...

  • Article
  • Open Access
28 Citations
7,420 Views
12 Pages

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

  • Tomokazu Kimizu,
  • Shinobu Ida,
  • Kentaro Okamoto,
  • Hiroyuki Awano,
  • Emma Tabe Eko Niba,
  • Yogik Onky Silvana Wijaya,
  • Shin Okazaki,
  • Hideki Shimomura,
  • Tomoko Lee and
  • Masakazu Shinohara
  • + 11 authors

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes degeneration of anterior horn cells in the human spinal cord and subsequent loss of motor neurons. The severe form of SMA is among the genetic diseases with the highest inf...

  • Article
  • Open Access
11 Citations
3,711 Views
16 Pages

Fine-Tuning of mTOR mRNA and Nucleolin Complexes by SMN

  • Francesca Gabanella,
  • Christian Barbato,
  • Marco Fiore,
  • Carla Petrella,
  • Marco de Vincentiis,
  • Antonio Greco,
  • Antonio Minni,
  • Nicoletta Corbi,
  • Claudio Passananti and
  • Maria Grazia Di Certo

4 November 2021

Increasing evidence points to the Survival Motor Neuron (SMN) protein as a key determinant of translation pathway. Besides its role in RNA processing and sorting, several works support a critical implication of SMN in ribosome biogenesis. We previous...

  • Review
  • Open Access
19 Citations
12,868 Views
33 Pages

Drug Discovery of Spinal Muscular Atrophy (SMA) from the Computational Perspective: A Comprehensive Review

  • Li Chuin Chong,
  • Gayatri Gandhi,
  • Jian Ming Lee,
  • Wendy Wai Yeng Yeo and
  • Sy-Bing Choi

20 August 2021

Spinal muscular atrophy (SMA), one of the leading inherited causes of child mortality, is a rare neuromuscular disease arising from loss-of-function mutations of the survival motor neuron 1 (SMN1) gene, which encodes the SMN protein. When lacking the...

  • Review
  • Open Access
4 Citations
2,560 Views
16 Pages

MicroRNAs as Biomarkers in Spinal Muscular Atrophy

  • Maruša Barbo,
  • Damjan Glavač,
  • Gregor Jezernik and
  • Metka Ravnik-Glavač

Spinal muscular atrophy (SMA) is a severe neurodegenerative disease caused by the loss of the survival motor neuron (SMN) protein, leading to degeneration of anterior motor neurons and resulting in progressive muscle weakness and atrophy. Given that...

of 2